Monopar Therapeutics (MNPR) Other Working Capital Changes (2017 - 2020)
Historic Other Working Capital Changes for Monopar Therapeutics (MNPR) over the last 4 years, with Q3 2020 value amounting to $76609.0.
- Monopar Therapeutics' Other Working Capital Changes rose 92624.03% to $76609.0 in Q3 2020 from the same period last year, while for Sep 2020 it was -$59419.0, marking a year-over-year increase of 4680.48%. This contributed to the annual value of $21792.0 for FY2024, which is 677.12% up from last year.
- As of Q3 2020, Monopar Therapeutics' Other Working Capital Changes stood at $76609.0, which was up 92624.03% from -$164342.0 recorded in Q2 2020.
- Monopar Therapeutics' 5-year Other Working Capital Changes high stood at $139557.0 for Q4 2017, and its period low was -$164342.0 during Q2 2020.
- Over the past 4 years, Monopar Therapeutics' median Other Working Capital Changes value was -$1704.0 (recorded in 2017), while the average stood at $5055.4.
- In the last 5 years, Monopar Therapeutics' Other Working Capital Changes surged by 252811.03% in 2018 and then crashed by 210209.03% in 2020.
- Over the past 4 years, Monopar Therapeutics' Other Working Capital Changes (Quarter) stood at $139557.0 in 2017, then tumbled by 183.36% to -$116330.0 in 2018, then skyrocketed by 88.16% to -$13770.0 in 2019, then surged by 656.35% to $76609.0 in 2020.
- Its Other Working Capital Changes stands at $76609.0 for Q3 2020, versus -$164342.0 for Q2 2020 and $42084.0 for Q1 2020.